APA引文

Topp, M. S., Gökbuget, N., Zugmaier, G., Degenhard, E., Goebeler, M., Klinger, M., . . . Bargou, R. C. (2012). Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.

Chicago Style (17th ed.) Citation

Topp, Max S., et al. Long-term Follow-up of Hematologic Relapse-free Survival in a Phase 2 Study of Blinatumomab in Patients with MRD in B-lineage ALL. 2012.

MLA引文

Topp, Max S., et al. Long-term Follow-up of Hematologic Relapse-free Survival in a Phase 2 Study of Blinatumomab in Patients with MRD in B-lineage ALL. 2012.